The drug interaction of clopidogrel carboxylic acid and atorvastatin: A study based on bioinformatic analysis

被引：0
|
作者：
Yan, Gao [1 ]
Zhong, Ping [1 ]
Fan, Li [2 ]
Lu, Xue-Chun [3 ]
Pei, Jing [1 ]
Meng, Xiao-yan [1 ]
机构：
[1] Jinan Mil Reg, Gen Hosp, Dept Cadre Ward 2, Jinan, Shandong, Peoples R China
[2] Peoples Liberat Army Gen Hosp, Geriatr Cardiol Div 1, Jinan, Peoples R China
[3] Peoples Liberat Army Gen Hosp, Dept Geriatr Hematol, Jinan, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2014.06.077
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW25-e5249
引用
收藏
页码：C15 / C15
页数：1
相关论文
共 50 条
  • [11] Simultaneous HPTLC Analysis of Aspirin, Atorvastatin Calcium and Clopidogrel Bisulphate in the Bulk Drug and in Capsules
    Londhe, S. V.
    Mulgund, S. V.
    Deshmukh, R. S.
    Jain, K. S.
    ACTA CHROMATOGRAPHICA, 2010, 22 (02) : 297 - 305
  • [12] Development and Validation of an HPLC Method for Simultaneous Quantification of Clopidogrel Bisulfate, Its Carboxylic Acid Metabolite, and Atorvastatin in Human Plasma: Application to a Pharmacokinetic Study
    Croitoru, Octavian
    Spiridon, Adela-Maria
    Belu, Ionela
    Turcu-Stiolica, Adina
    Neamtu, Johny
    JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY, 2015, 2015
  • [13] A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
    Juurlink, David N.
    Gomes, Tara
    Ko, Dennis T.
    Szmitko, Paul E.
    Austin, Peter C.
    Tu, Jack V.
    Henry, David A.
    Kopp, Alex
    Mamdani, Muhammad M.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (07) : 713 - 718
  • [14] DRUG INTERACTION STUDIES OF ATORVASTATIN AND OTHER DRUGS BASED ON BIOINFORMATICS
    Gao, Yan
    Fan, Li
    Lu, Xue-Chun
    Cao, Jian
    Zhao, Xia
    Pei, Jing
    Meng, Xiao-yan
    Fan, Li
    HEART, 2012, 98 : E21 - E21
  • [15] Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial
    Saw, J
    Steinhubl, SR
    Berger, PB
    Kereiakes, DJ
    Serebruany, VL
    Brennan, D
    Topol, EJ
    CIRCULATION, 2003, 108 (08) : 921 - 924
  • [16] Pharmaco-epidemiological study of the interaction between atorvastatin and clopidogrel following percutaneous coronary interventions
    Brophy, J
    Costa, V
    Babapulle, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 50A - 50A
  • [17] A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors
    Cressman, Alex M.
    Macdonald, Erin M.
    Fernandes, Kimberly A.
    Gomes, Tara
    Paterson, J. Michael
    Mamdani, Muhammad M.
    Juurlink, David N.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 662 - 669
  • [18] Atorvastatin does not inhibit clopidogrel in patients undergoing coronary stenting in prospective data from the INTERACTION study
    Serebruany, V
    Midei, M
    Malinin, A
    Lowry, D
    Oshrine, B
    Steinhubl, S
    Sane, D
    Berger, P
    Tanguay, JF
    O'Connor, C
    Hennekens, C
    CIRCULATION, 2003, 108 (17) : 674 - 674
  • [19] Omeprazole and atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation in patients undergoing percutaneous coronary intervention in a tertiary health care system: A prospective drug-drug interaction study
    Nagavi, Jinesh Bahubali
    Gurupadayya, Bannimath
    Anantharaju, Preethi Gotadake
    IJC METABOLIC & ENDOCRINE, 2016, 13 : 35 - 40
  • [20] Pharmacokinetic Drug-Drug Interaction Study Between Raltegravir and Atorvastatin 20 mg in Healthy Volunteers
    Blonk, Maren
    van Beek, Michiel
    Colbers, Angela
    Schouwenberg, Bas
    Burger, David
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (01) : 44 - 51
12345